BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2021 8:37:41 AM | Browse: 425 | Download: 798
 |
Received |
|
2021-03-16 14:55 |
|
Peer-Review Started |
|
2021-03-16 15:32 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-05 05:00 |
|
Revised |
|
2021-06-29 13:40 |
|
Second Decision |
|
2021-11-30 03:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-11-30 19:20 |
|
Articles in Press |
|
2021-11-30 19:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-11-16 03:43 |
|
Typeset the Manuscript |
|
2021-12-13 09:13 |
|
Publish the Manuscript Online |
|
2021-12-25 08:37 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Review |
| Article Title |
Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tong-Ming Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tong-Ming Liu, PhD, Senior Research Fellow, Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, 8A Biomedical Grove, Immunos, Singapore 138648, Singapore. dbsliutm@yahoo.com |
| Key Words |
Human pluripotent stem cells; Differentiation; Mesenchymal stem cells; Regenerative medicine; Disease modelling; Drug screening |
| Core Tip |
Mesenchymal stem cells (MSCs) exhibit great potential in regenerative medicine. However, the clinical application of primary MSCs has been greatly hampered by the limitations of primary MSCs. MSCs derived from human pluripotent stem cells (hPSC-MSCs) are an attractive source of cells to overcome such problems with primary MSCs. This review summarizes the various derivation approaches and applications of hPSC-MSCs in regenerative medicine. Lastly, the challenges with the use of hPSC-MSCs are also discussed, which indicate that more efforts are needed for the clinical application of hPSC-MSCs. |
| Publish Date |
2021-12-25 08:37 |
| Citation |
Liu TM. Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine. World J Stem Cells 2021; 13(12): 1826-1844 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i12/1826.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i12.1826 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
